Y. Liu

The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV

F. Zhu, J. Yu, J. Chen, 2022, medRxiv.

Immune response of primary and booster immunity of SARS-CoV-2 vaccination among patients with chronic liver disease: a real-world study

Y. Li, F. Wang, J. Li, 2022, medRxiv.

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

Tian Yang, Yefa Yang, Ai-Jun Li, 2010, British Journal of Cancer.

Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression

K. He, Y. Yang, W. Shi, 2016, Oncogene.

CD9 is a leukemic stem cell-specific marker in human acute myeloid leukemia

G. Wang, J. Li, H. Xu, 2020 .

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy

W. Lau, X. Wan, Jingfeng Liu, 2014, British Journal of Cancer.

Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation.

L. Gan, J. Du, Z. Tao, 2015, Genetics and Molecular Research.